BUNCH CHARLES E
BUNCH CHARLES E's purchase track record
BUNCH CHARLES E has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/24/2021 | MPC | $64K | +18.2% | +55.5% | -15.4% |
| 11/5/2021 | MDLZ | $62K | +8.2% | +6.7% | -12.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Mondelez Sets Q3 Earnings Date and Promotes Halloween Snacks. Mondelez International announced it will report third-quarter 2026 financial results on October 29, 2026. The company is also promoting its Sour Patch Kids brand with new Halloween-themed products and collaborations. Recent market chatter has focused on the safety of the company's dividend payout, while its stock currently trades near the top of its 52-week range.
Transaction History
| MPC | ▲ Buy | Grant | 94 | $0 | 4/1/2025 | View on chart |
| MPC | ▲ Buy | Grant | 294 | $0 | 1/2/2025 | View on chart |
| MPC | ▲ Buy | Grant | 251 | $0 | 10/1/2024 | View on chart |
| MPC | ▲ Buy | Grant | 225 | $0 | 7/1/2024 | View on chart |
| MDLZ | ▲ Buy | Grant | 2,849 | $0 | 5/22/2024 | View on chart |
| MPC | ▲ Buy | Grant | 193 | $0 | 4/1/2024 | View on chart |
| MPC | ▲ Buy | Grant | 258 | $0 | 1/2/2024 | View on chart |
| MPC | ▲ Buy | Grant | 262 | $0 | 10/2/2023 | View on chart |
| MPC | ▲ Buy | Grant | 335 | $0 | 7/3/2023 | View on chart |
| MDLZ | ▲ Buy | Grant | 2,461 | $0 | 5/17/2023 | View on chart |
| MPC | ▲ Buy | Grant | 290 | $0 | 4/3/2023 | View on chart |
| MPC | ▲ Buy | Grant | 355 | $0 | 1/3/2023 | View on chart |
| MPC | ▲ Buy | Grant | 383 | $0 | 10/3/2022 | View on chart |
| MPC | ▲ Buy | Grant | 466 | $0 | 7/1/2022 | View on chart |
| MDLZ | ▲ Buy | Grant | 3,118 | $0 | 5/18/2022 | View on chart |
| MPC | ▲ Buy | Grant | 464 | $0 | 4/1/2022 | View on chart |
| MPC | ▲ Buy | Grant | 600 | $0 | 1/3/2022 | View on chart |
| MPC | ▲ Buy | Open Market | 1,000 | $64K | 11/24/2021 | View on chart |
| MDLZ | ▲ Buy | Open Market | 1,000 | $62K | 11/5/2021 | View on chart |
| MPC | ▲ Buy | Grant | 619 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Marathon Petroleum: Analyst Fair Value Boost Amid Market Declines
Recent analysis highlights that analysts have lifted refining assumptions, boosting the fair value estimate for Marathon Petroleum. At the same time, the company's stock has declined while the broader market improved, prompting comparisons with peers like Delek US. These reports also discuss the impact of diesel market dynamics on the company's refining margins and its potential as a defensive hedge in the current energy environment.
Marathon Petroleum: Analyst Fair Value Boost Amid Market Declines. Recent analysis highlights that analysts have lifted refining assumptions, boosting the fair value estimate for Marathon Petroleum. At the same time, the company's stock has declined while the broader market improved, prompting comparisons with peers like Delek US. These reports also discuss the impact of diesel market dynamics on the company's refining margins and its potential as a defensive hedge in the current energy environment.